Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2009 2
2010 5
2011 2
2012 4
2013 2
2014 9
2015 7
2016 3
2017 6
2018 7
2019 2
2020 11
2021 6
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Jayavelu AK, Schnöder TM, Perner F, Herzog C, Meiler A, Krishnamoorthy G, Huber N, Mohr J, Edelmann-Stephan B, Austin R, Brandt S, Palandri F, Schröder N, Isermann B, Edlich F, Sinha AU, Ungelenk M, Hübner CA, Zeiser R, Rahmig S, Waskow C, Coldham I, Ernst T, Hochhaus A, Jilg S, Jost PJ, Mullally A, Bullinger L, Mertens PR, Lane SW, Mann M, Heidel FH. Jayavelu AK, et al. Among authors: mullally a. Nature. 2020 Dec;588(7836):157-163. doi: 10.1038/s41586-020-2968-3. Epub 2020 Nov 25. Nature. 2020. PMID: 33239784
Molecular Pathogenesis of Myeloproliferative Neoplasms.
Rolles B, Mullally A. Rolles B, et al. Among authors: mullally a. Curr Hematol Malig Rep. 2022 Dec;17(6):319-329. doi: 10.1007/s11899-022-00685-1. Epub 2022 Nov 7. Curr Hematol Malig Rep. 2022. PMID: 36336766 Review.
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.
Mullally A, Lane SW, Ball B, Megerdichian C, Okabe R, Al-Shahrour F, Paktinat M, Haydu JE, Housman E, Lord AM, Wernig G, Kharas MG, Mercher T, Kutok JL, Gilliland DG, Ebert BL. Mullally A, et al. Cancer Cell. 2010 Jun 15;17(6):584-96. doi: 10.1016/j.ccr.2010.05.015. Cancer Cell. 2010. PMID: 20541703 Free PMC article.
Murine Models of Myelofibrosis.
Jacquelin S, Kramer F, Mullally A, Lane SW. Jacquelin S, et al. Among authors: mullally a. Cancers (Basel). 2020 Aug 23;12(9):2381. doi: 10.3390/cancers12092381. Cancers (Basel). 2020. PMID: 32842500 Free PMC article. Review.
Fedratinib in myelofibrosis.
Mullally A, Hood J, Harrison C, Mesa R. Mullally A, et al. Blood Adv. 2020 Apr 28;4(8):1792-1800. doi: 10.1182/bloodadvances.2019000954. Blood Adv. 2020. PMID: 32343799 Free PMC article.
The Molecular Genetics of Myeloproliferative Neoplasms.
Marneth AE, Mullally A. Marneth AE, et al. Among authors: mullally a. Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034876. doi: 10.1101/cshperspect.a034876. Cold Spring Harb Perspect Med. 2020. PMID: 31548225 Free PMC article. Review.
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.
Jutzi JS, Marneth AE, Ciboddo M, Guerra-Moreno A, Jiménez-Santos MJ, Kosmidou A, Dressman JW, Liang H, Hamel R, Lozano P, Rumi E, Doench JG, Gotlib J, Krishnan A, Elf S, Al-Shahrour F, Mullally A. Jutzi JS, et al. Among authors: mullally a. Blood. 2022 Sep 15;140(11):1291-1304. doi: 10.1182/blood.2022015629. Blood. 2022. PMID: 35763665 Free PMC article.
Myeloproliferative neoplasm stem cells.
Mead AJ, Mullally A. Mead AJ, et al. Among authors: mullally a. Blood. 2017 Mar 23;129(12):1607-1616. doi: 10.1182/blood-2016-10-696005. Epub 2017 Feb 3. Blood. 2017. PMID: 28159736 Free PMC article. Review.
68 results